 U.S. News & World Report | Bristol-Myers executive charged with insider trading Reuters (Reuters) - A Bristol-Myers Squibb Co executive was criminally charged with insider trading, accused of trading options in three companies that the large drugmaker was looking to buy. Prosecutors said Robert Ramnarine, 45, made $311361 in illegal ... Bristol-Myers Executive Accused of Insider Trading Bristol-Myers exec charged with insider trading Bristol-Myers suspends hepatitis C treatment study |
Thursday, August 2, 2012
Bristol-Myers executive charged with insider trading - Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment